Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5525
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Targeting P21 activated kinase 1 (PAK1) in Pancreatic stellate cell mediated Fibrosis p: A potential therapeutic approach | Dr. Suresh Kumar Rayala, Professor, Department of Biotechnology, Indian Institute of Technology (IIT), Chennai, Tamil Nadu | 2016 | Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India | Pancreatic stellate cell mediated Fibrosis p |
| Targeting persistent infections and multi-drug resistance in bacterial infections and biofilms using engineered synergistic bile acid amphiphile-drug conjugates | Dr. Avinash Bajaj, Associate Professor, Regional Centre For Biotechnology (RCB), Faridabad | 2015 | Department of Biotechnology (DBT), Government of Inida | Bacterial infections and biofilms |
| Targeting redox-regulated signaling system for radioprotection using grape proanthocyanidins- Amolecular approach for product development | Dr. K.D. Saha Principal Technical Officer CSIR-Indian Institute of Chemical Biology 4, Raja S.C. Mullick Road West Bengal | 2020 | Defence Research and Development Organisation (DRDO) | Life Science |
| Targeting RNA driven processes: Novel chemical biology approaches to identify new classes of RNA modulators | Dr Suvendra Nath Bhattacharyya, Scientist, CSIR-Indian Institute of Chemical Biology (CSIR-IICB), Kolkata | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | RNA driven processes |
| Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers | Dr. Shantanu Chowdhury, Scientist, Institute of Genomics and Integrative Biology(IGIB), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Drug resistant cancer |
| Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers | Dr. Tushar Kanti Chakraborty, Professor, Department of Organic Chemistry, Indian Institute of Science (IISc), Bengaluru, Karnataka | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Drug resistant cancer |
| Targeting the DNAG-DNAB interaction in Mycobacterium tuberculosis to identify and validate suitable small molecule inhibitors | Dr. Manju Yasoda Krishnan, Scientist, Department of Microbiology, Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh | 2016 | Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Govt. of India | Mycobacterium tuberculosis |
| Targeting the miRNA axis with a synthetic small molecule,Nifetepimine to restrict migration of triple negative breat cancer cells | Prof Parimal C. Sen, Head, Division of Molecular Medicine, Bose Institute, Kolkata, West Bengal | 2016 | Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Govt. of India | Breat cancer cells |
| Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 for the development of inhibitors | Prof Benu Brata Das, Indian Association for the Cultivation of Science (IACS), Kolkata | 2020 | Department of Science and Technology (DST), Govt of India | Therapeutics for COVID-19 |
| Targeting Xenoobiotic efflux transporters & cytochrome P450: Exploring a novel approach to mitigate pesticide toxicity | Dr. S. Bhattacharjee, Assistant Professor, West Bengal State University, West Bengal | 2019 | Department of Science and Technology, (DST) | Science & Engineering Research Board - Core Research Grant, SERB-CRG |